Faeth Therapeutics Inc stock is traded at $7.88, with a volume of 419,005. It is down -9.32% in the last 24 hours and down -62.10% over the past month. Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Previous Close:
$8.69
Open:
$8.52
24h Volume:
419,005
Relative Volume:
0.37
Market Cap:
$203.65M
Revenue:
-
Net Income/Loss:
-$184.46M
P/E Ratio:
-
EPS:
-$142.73
Net Cash Flow:
-$24.11M
1W Performance:
-21.44%
1M Performance:
-62.10%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$7.84$9.13
1-Week Range:
$7.84$10.26
52-Week Range:
$7.84$42.14
Faeth Therapeutics Inc Stock (FTH) Company Profile
Name
Faeth Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(240) 243-8000Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS